Anti-CA9/CAIX Antibody (Girentuximab)
Catalog No.
F1447
Anti-CA9/CAIX Antibody (Girentuximab)
Featured Products
Girentuximab (G250) is a chimeric monoclonal antibody that binds to carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.62 kDa
Dry ice
916138-87-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
89ZR-TX250
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q16790
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
U87-MG cells were stained with Anti-CA9/CAIX Antibody (Girentuximab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50 is 0.13 ug/mL.
CA9 / CAIX
Please avoid freeze-thaw cycles.